BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 2642977)

  • 1. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation.
    Hinds P; Finlay C; Levine AJ
    J Virol; 1989 Feb; 63(2):739-46. PubMed ID: 2642977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p53 proto-oncogene can act as a suppressor of transformation.
    Finlay CA; Hinds PW; Levine AJ
    Cell; 1989 Jun; 57(7):1083-93. PubMed ID: 2525423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.
    Finlay CA; Hinds PW; Tan TH; Eliyahu D; Oren M; Levine AJ
    Mol Cell Biol; 1988 Feb; 8(2):531-9. PubMed ID: 2832726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p53-plus-ras-transformed cell lines.
    Hinds PW; Finlay CA; Frey AB; Levine AJ
    Mol Cell Biol; 1987 Aug; 7(8):2863-9. PubMed ID: 3313006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p53 tumor suppressor gene and gene product.
    Levine AJ
    Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simian virus 40 large T antigen contains two independent activities that cooperate with a ras oncogene to transform rat embryo fibroblasts.
    Cavender JF; Conn A; Epler M; Lacko H; Tevethia MJ
    J Virol; 1995 Feb; 69(2):923-34. PubMed ID: 7815561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of p53 cellular tumour antigen in transformation of normal embryonic cells.
    Eliyahu D; Raz A; Gruss P; Givol D; Oren M
    Nature; 1984 Dec 13-19; 312(5995):646-9. PubMed ID: 6095116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutant p53 protein is required for maintenance of the transformed phenotype in cells transformed with p53 plus ras cDNAs.
    Zambetti GP; Olson D; Labow M; Levine AJ
    Proc Natl Acad Sci U S A; 1992 May; 89(9):3952-6. PubMed ID: 1570319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cellular oncogene p53 can be activated by mutagenesis.
    Jenkins JR; Rudge K; Chumakov P; Currie GA
    Nature; 1985 Oct 31-Nov 6; 317(6040):816-8. PubMed ID: 3903515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes.
    Hinds PW; Finlay CA; Quartin RS; Baker SJ; Fearon ER; Vogelstein B; Levine AJ
    Cell Growth Differ; 1990 Dec; 1(12):571-80. PubMed ID: 2288874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperation of p53 and polyoma virus middle T antigen in the transformation of primary rat embryo fibroblasts.
    Reihsaus E; Kraiss S; Barnekow A; Montenarh M
    Exp Cell Res; 1992 Mar; 199(1):10-8. PubMed ID: 1735451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immortalization of rat embryo fibroblasts by the cellular p53 oncogene.
    Rovinski B; Benchimol S
    Oncogene; 1988 May; 2(5):445-52. PubMed ID: 3287278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A modified p53 overcomes mdm2-mediated oncogenic transformation: a potential cancer therapeutic agent.
    Lin J; Jin X; Page C; Sondak VK; Jiang G; Reynolds RK
    Cancer Res; 2000 Oct; 60(20):5895-901. PubMed ID: 11059788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wild-type p53 can inhibit oncogene-mediated focus formation.
    Eliyahu D; Michalovitz D; Eliyahu S; Pinhasi-Kimhi O; Oren M
    Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8763-7. PubMed ID: 2530586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth.
    Finlay CA
    Mol Cell Biol; 1993 Jan; 13(1):301-6. PubMed ID: 8417333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53-plus-ras-transformed rat embryo fibroblasts express tumor-specific transplantation antigen activity which is shared by independently transformed cells.
    Frey AB; Levine AJ
    J Virol; 1989 Dec; 63(12):5440-4. PubMed ID: 2531235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of oncogene cooperation: activation and inactivation of a growth antagonist.
    Ragozzino MM; Kuo A; DeGregori J; Kohl N; Ruley HE
    Environ Health Perspect; 1991 Jun; 93():97-103. PubMed ID: 1837777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of normal human p53 in established fibroblasts leads to their tumorigenic conversion.
    Tuck SP; Crawford L
    Oncogene Res; 1989; 4(2):81-96. PubMed ID: 2654816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoplastic transformation of normal rat embryo fibroblasts by a mutated p53 and an activated ras oncogene induces parathyroid hormone-related peptide gene expression and causes hypercalcemia in nude mice.
    Motokura T; Endo K; Kumaki K; Ogata E; Ikeda K
    J Biol Chem; 1995 Dec; 270(52):30857-61. PubMed ID: 8537338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental metastasis in nude mice of NIH 3T3 cells containing various ras genes.
    Bradley MO; Kraynak AR; Storer RD; Gibbs JB
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5277-81. PubMed ID: 3523488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.